Skip to main content
SpringerLink
Log in

Locally Advanced/Unresectable Pancreatic Cancer

  • Chapter
  • First Online:
Gastrointestinal Malignancies

Part of the book series: Practical Guides in Radiation Oncology ((PGRO))

  • 1128 Accesses

Abstract

When pancreatic cancer is not resectable or metastatic, it is classified as locally advanced pancreatic cancer. The majority of patients diagnosed with localized pancreatic cancer present with locally advanced disease. Currently, there is no consensus for optimal treatment of locally advanced pancreatic cancer. There has been much debate and controversy with regard to the best upfront treatment modality (chemotherapy and radiotherapy), sequencing of chemotherapy and radiation, and specific nuances of chemotherapy agents and radiation treatment techniques. The aims of treatment are to extend survival and improve quality of life by preventing development of distant metastatic disease and progression of local disease. Without surgery, the prognosis of these patients remains poor. This chapter provides a guide for management of locally advanced pancreatic cancer, with a predominant focus on radiation therapy planning.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  1. Iacobuzio-Donahue CA, et al. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol. 2009;27(11):1806–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Hidalgo M. Pancreatic cancer. N Engl J Med. 2010;362(17):1605–17.

    Article  CAS  PubMed  Google Scholar 

  3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.

    Article  PubMed  Google Scholar 

  4. Moertel CG, et al. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer. 1981;48(8):1705–10.

    Article  CAS  PubMed  Google Scholar 

  5. Hammel P, et al. Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 randomized clinical trial. JAMA. 2016;315(17):1844–53.

    Article  CAS  PubMed  Google Scholar 

  6. Thompson RF, et al. A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas. Med Phys. 2014;41(8):081711.

    Article  PubMed  Google Scholar 

  7. Terashima K, et al. A phase I/II study of gemcitabine-concurrent proton radiotherapy for locally advanced pancreatic cancer without distant metastasis. Radiother Oncol. 2012;103(1):25–31.

    Article  PubMed  Google Scholar 

  8. Takatori K, et al. Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer. J Gastroenterol. 2014;49(6):1074–80.

    Article  CAS  PubMed  Google Scholar 

  9. Koong AC, et al. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2004;58(4):1017–21.

    Article  PubMed  Google Scholar 

  10. Schellenberg D, et al. Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2008;72(3):678–86.

    Article  CAS  PubMed  Google Scholar 

  11. Schellenberg D, et al. Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2011;81(1):181–8.

    Article  PubMed  Google Scholar 

  12. Herman JM, et al. Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma. Cancer. 2015;121(7):1128–37.

    Article  CAS  PubMed  Google Scholar 

  13. Hoyer M, et al. Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother Oncol. 2005;76(1):48–53.

    Article  PubMed  Google Scholar 

  14. Taniguchi CM, et al. Dosimetric analysis of organs at risk during expiratory gating in stereotactic body radiation therapy for pancreatic cancer. Int J Radiat Oncol Biol Phys. 2013;85(4):1090–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MD Anderson Cancer Center, Houston, TX, USA

    Sweet Ping Ng M.B.B.S., B.Med.Sci., Michael E. Kantor B.S., Sam Beddar Ph.D., Eugene Koay M.D., Ph.D., Joseph Herman M.D. & Cullen M. Taniguchi M.D., Ph.D.

Authors
  1. Sweet Ping Ng M.B.B.S., B.Med.Sci.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael E. Kantor B.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sam Beddar Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eugene Koay M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Joseph Herman M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Cullen M. Taniguchi M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Radiation Oncology, Case Western Reserve University, Cleveland, Ohio, USA

    Suzanne Russo

  2. Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida, USA

    Sarah Hoffe

  3. Department of Radiation Oncology, University of Washington School of Medicine, Seattle, Washington, USA

    Edward Kim

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Ng, S.P., Kantor, M.E., Beddar, S., Koay, E., Herman, J., Taniguchi, C.M. (2018). Locally Advanced/Unresectable Pancreatic Cancer. In: Russo, S., Hoffe, S., Kim, E. (eds) Gastrointestinal Malignancies. Practical Guides in Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-64900-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-64900-9_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-64899-6

  • Online ISBN: 978-3-319-64900-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation